Akero Therapeutics Inc.

News & Events

Press Releases

In The Media

1. Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

   GlobeNewswire JUN 3, 2025 7:00 AM EDT
   SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. ...
   READ ARTICLE

2. Akero Therapeutics to Present at the Jefferies Global Healthcare Conference

   GlobeNewswire MAY 28, 2025 7:00 AM EDT
   SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. ...
   READ ARTICLE

3. Akero Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

   GlobeNewswire MAY 12, 2025 7:00 AM EDT
   Phase 2b SYMMETRY study preliminary results showed statistically significant reversal of compensa...
   READ ARTICLE

4. Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025

   GlobeNewswire MAY 10, 2025 10:00 AM EDT
   Analysis of EFX results with AI-based digital pathology underscores the potential value in evalua...
   READ ARTICLE

5. Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine

   GlobeNewswire MAY 9, 2025 7:11 AM EDT
   Results support potential benefit of efruxifermin (EFX) to elicit fibrosis improvement in patient...
   READ ARTICLE

6. Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025

   GlobeNewswire MAY 9, 2025 6:15 AM EDT
   SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: A...
   READ ARTICLE

7. Akero Therapeutics to Present at the BofA Securities 2025 Healthcare Conference

   GlobeNewswire MAY 7, 2025 4:05 PM EDT
   SOUTH SAN FRANCISCO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. ...
   READ ARTICLE

8. Long-Term Shareholders Have Rights - If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar Law Office

   GlobeNewswire MAY 5, 2025 9:51 AM EDT
   PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ: AKRO): ...
   READ ARTICLE

9. Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025

   GlobeNewswire APR 30, 2025 7:00 AM EDT
   SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq:...
   READ ARTICLE

10. INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to Contact Law Firm

    GlobeNewswire APR 23, 2025 3:44 PM EDT
    NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Moore Law, PLLC, a shareholder litigation law firm l...
    READ ARTICLE